On December 5, 2024, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) on the “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Peptides and Peptide Microarrays for Detection and Differentiation of Antibody Responses to Ebola… Continue Reading
On Wednesday, 4 December 2024, Knowledge Ecology International (KEI) delivered this statement on Article 6 – Administration of [rights/interests] at the 49th session of the World Intellectual Property Organization’s Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and… Continue Reading
Article-3-WIPO-DLT-18nov2024
KEI closing statement at INB 12 Geneva Friday, 15 November 2024 We welcome the decision to provide daily access to the negotiating texts, but more needs to be done on transparency. The excessive secrecy surrounding the WHO pandemic treaty is… Continue Reading
On Thursday, 14 November 2024, Knowledge Ecology International (KEI) delivered the following statement on Article 11 on the transfer of technology and know-how for the production of pandemic related health products. In several interventions and in talks with negotiators, KEI… Continue Reading
kei-bn-2024-8 KEI Briefing Note 2024:8. The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency November 12, 2024
kei-bn-2024-8 KEI Briefing Note 2024:8 The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency November 12, 2024
KEI talking points on Article 11 7 November 2024 The proposed New 1(j) footnote under Article 11 for INB12 is a complex way of saying that countries will make efforts to negotiate voluntary agreements on technology transfer, but if that… Continue Reading
On November 1, 2024, Knowledge Ecology International (KEI) submitted a proposal for the addition of risdiplam to the World Health Organization’s (WHO) Model List of Essential Medicine (EML). You can access the full proposal here: risdiplam2WHOEML1Nov2024 The EML, updated every… Continue Reading
KEI-NIH-T-Cure-Biosciences22Oct2024 Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in… Continue Reading